Michael Fumento

Geron Corp. has announced that the FDA has again put on hold what we've long been told will be the first clinical trial involving embryonic stem cells.

If you're not shocked, it's because you don't know that it has been portrayed as the first human clinical trial since 2002 when lead scientist Hans Keirstead said his much-celebrated study on partially-paralyzed rats would be replicated as soon as the next year. As I've written repeatedly over the years, most recently in Forbes Online, somehow those "just around the corner" treatments for ES cells keep being a corner too far.